Results · Apr-Jun 2026
ZIM Laboratories Q1 FY27 results
Sales grew 31% to ₹94.2 crore from ₹71.8 crore in Apr-Jun 2025.
Operating profit fell 42% to ₹2.5 crore, an operating margin of 2.6% (down 3.3 points from a year ago).
The net loss widened to ₹4 crore from ₹1.9 crore.
Against Jan-Mar 2026: sales −11%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 94.2 | 71.8 | +31% |
| Operating profit (EBITDA) | 2.5 | 4.3 | −42% |
| Operating margin | 2.6% | 5.9% | −3.3 pts |
| Net profit | -4.0 | -1.9 | loss widens |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.